Iterum Therapeutics (ITRM) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.93
-0.68
-0.43
-0.17

Details

Expected EPS
-0.175
Actual EPS
-0.24
Surprise EPS
-0.07
Surprise Percent
-37.14%

Description

⁨Iterum Therapeutics⁩ (⁦ITRM⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts